Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evaluation of the Usefulness of an Automatable Immunoassay for Monitoring Celiac Disease by Quantification of Immunogenic Gluten Peptides in Urine

  • Segura, Verónica
  • Ruiz-Carnicer, Ángela
  • Mendia Azkoaga, Irati
  • Garzón-Benavides, Marta
  • Pizarro, Ángeles
  • Comino, Isabel
  • Sousa, Carolina
A gluten-free diet (GFD) is currently the only treatment available for patients with celiac disease (CD). However, adherence to a GFD can be challenging because gluten is present in many foods. A lifelong follow-up of patients with CD must be performed to promote adherence to a GFD and to identify the appearance of symptoms and the associated diseases. Therefore, the development of tools to analyze gluten exposure in these patients is important. This study proposes the development of the first automatable ELISA to monitor adherence to a GFD through the quantification of urine gluten immunogenic peptides (u-GIP). Seven healthy volunteers without suspicion of CD and 23 patients with CD were monitored as part of this study to optimize, validate, and apply this assay. Non-interference was found in the urine matrix, and the recovery percentage for spiked samples was 81-101%. The u-GIP was stable for up to 16 days when the samples were stored at different temperatures. Overall, 100% of the patients had detectable u-GIP at diagnosis (range of 0.39-2.14 ng GIP/mL), which reduced to 27% after 12 months on a GFD. Therefore, this highly sensitive immunoassay would allow the analysis of u-GIP from a large battery of samples in clinical laboratories of specialized healthcare centers., This research was funded by Grant DI-17-09627 and Grant RTC2019-006806-1 funded by MCIN/AEI/10.13039/501100011033, by Grant P18-RT-3004 funded by PAIDI I+D+i Junta de Andalucía (Consejería de Economía y Conocimiento), and by Grant AT17_5489_USE PAIDI Actividades de Transferencia 2017 Junta de Andalucía (Consejería de Economía, Conocimiento, Empresas y Universidad)., Peer reviewed
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Datos de investigación Set de datos (Dataset)

Acute Gluten-Induced Inflammatory Protein Signature in Celiac Disease: A Step Towards Biomarker Discovery, Firma proteica inflamatoria inducida agudamente por el gluten en la enfermedad celíaca: un paso hacia el descubrimiento de biomarcadores

  • Gómez Aguililla, Sara
  • Farrais Villalba, Sergio
  • López Palacios, Natalia
  • Arau, Beatriz
  • Senosiain, Carla
  • Infante Menéndez, Jorge
  • Ruiz Carnicer, Ángela
  • Fernández Bañares, Fernando
  • González López, Nuria
  • Pujals, Mar
  • Sousa, Carolina
  • Núñez Pardo de Vera, María Concepción
Relative concentrations of 74 inflammation-related serum proteins obtained by proximity extension assay (PEA, Olink) in patients with celiac disease and in non-celiac controls. Measurements were obtained while participants were on a gluten-free diet (≥1 month) at two time points: baseline (on GFD) and 4 hours after a single gluten challenge (10 g). NA indicates values below the limit of quantification., Background Diagnosis of celiac disease (CD) remains challenging in individuals already on a gluten-free diet (GFD). Although several alternative methods have been proposed, they have limitations. Identifying inflammation-related proteins that rapidly respond to gluten exposure in blood may offer diagnostic alternatives. Objective To characterize the inflammatory protein response to gluten in patients with CD on a GFD, and to assess the diagnostic potential of candidate biomarkers and their association with clinical symptoms. Methods Seventeen patients with CD and 15 non-CD individuals on a GFD (≥ 1 month) consumed 10 g of gluten. Serum, plasma and clinical symptoms were collected at baseline and 4 h post-gluten ingestion to assess changes in 92 inflammation-related proteins. Results Following gluten consumption, 18 proteins changed significantly only in patients with CD. Six showed an AUC ≥80%, and CCL20 achieved 85.7% sensitivity and 92.7% specificity for CD diagnosis. CCL20 level increases post-gluten challenge were higher in patients with vomiting but were also observed in those with absent or mild symptoms. Conclusion Gluten reintroduction triggers alterations in the inflammation-related protein profile of patients with CD. CCL20 emerges as a promising diagnostic candidate, its increase in plasma or serum, with low dependence on symptom presentation, may complement existing diagnostic approaches., Base de datos